NCT04843540View on ClinicalTrials.gov

Drug-drug Interaction Study of CTP-543 and Rifampin in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

May 19, 2021

Primary Completion Date

June 24, 2021

Study Completion Date

July 2, 2021

Conditions
Healthy Volunteers
Interventions
DRUG

CTP-543

Rifampin as oral capsule

Trial Locations (1)

33014

Clinical Pharmacology of Miami, Miami

Sponsors
All Listed Sponsors
lead

Concert Pharmaceuticals

INDUSTRY

NCT04843540 - Drug-drug Interaction Study of CTP-543 and Rifampin in Healthy Adult Subjects | Biotech Hunter | Biotech Hunter